Department of Neurology, North Karelia Central Hospital, Siun Sote, Joensuu, Finland; Neurocenter, Department of Neurology, Clinical Neurosciences, Turku University Hospital and University of Turku, Turku, Finland.
Neurocenter, Department of Neurology, Clinical Neurosciences, Turku University Hospital and University of Turku, Turku, Finland.
J Neurol Sci. 2021 Jun 15;425:117446. doi: 10.1016/j.jns.2021.117446. Epub 2021 Apr 14.
Case-fatality of Intracerebral hemorrhage (ICH) has been reported to have improved in some areas recently. Previous reports have shown that in Finland ICH survival has improved already from the 1980s. We aimed to investigate if this trend has continued and to assess possible predictors for death.
All patients hospitalized for ICH in Finland in 2004-2018 over 16 years of age were identified from a national registry. Survival was analyzed using the national causes of death registry with median follow-up of 5.1 years (max 15.0 years).
20,391 persons with ICH (53.5% men) were identified. Patient age increased during the study period with men being younger than women. One-month case-fatality was 28.4% and decreased during the study period. One-month and long-term case-fatality increased with patient age. Five-year survival was over 64% in patients <65 years of age and < 33% in those >75 years of age. In a multivariate analysis patient age, sex, comorbidity burden and diagnoses of atrial fibrillation, hypertension and coagulopathy were all independently associated with both 30-day and long-term survival. Survival was better in men than women at all time points but in the multivariate analysis male sex was associated with a slightly higher risk (hazard ratio 1.10, 95% CI 1.06-1.14) of death in the long-term follow-up. Compared to general population, excess case-fatality was high and highly age-dependent in both sexes.
Case-fatality of hospital-treated ICH has continued to decrease in Finland. Prognosis is strongly associated with patient age and more modestly with patient sex and comorbidities.
最近有报道称,一些地区的脑出血(ICH)病死率有所下降。之前的报告显示,芬兰的 ICH 存活率已经从 20 世纪 80 年代开始提高。我们旨在调查这一趋势是否持续,并评估可能的死亡预测因素。
从国家登记处确定了 2004 年至 2018 年在芬兰住院治疗的所有年龄在 16 岁以上的 ICH 患者。使用国家死因登记处分析生存情况,中位随访时间为 5.1 年(最长 15.0 年)。
共确定了 20391 例 ICH 患者(53.5%为男性)。研究期间,患者年龄逐渐增加,男性比女性年轻。1 个月的病死率为 28.4%,且研究期间呈下降趋势。1 个月和长期病死率随患者年龄增加而增加。年龄<65 岁的患者 5 年生存率超过 64%,年龄>75 岁的患者生存率<33%。多变量分析显示,患者年龄、性别、合并症负担以及房颤、高血压和凝血障碍的诊断均与 30 天和长期生存独立相关。在所有时间点,男性的生存率均高于女性,但在多变量分析中,男性与长期随访时死亡风险略有增加(危险比 1.10,95%CI 1.06-1.14)。与一般人群相比,两性的病死率均较高,且高度依赖于年龄。
芬兰医院治疗的 ICH 病死率继续下降。预后与患者年龄密切相关,与患者性别和合并症有一定关系。